Viloxazine is available as a generic medication [1]. It is a selective norepinephrine reuptake inhibitor used to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric patients [2].
When did the brand-name drug patent expire?
The brand-name drug for viloxazine, Qelbree, is marketed by Supernus Pharmaceuticals. Information on the specific patent expiry dates for Qelbree may be found on resources that track drug patents [3].
How does viloxazine work to treat ADHD?
Viloxazine functions by increasing the levels of norepinephrine, a neurotransmitter, in the brain [2]. Norepinephrine plays a role in attention and impulse control, and by enhancing its availability, viloxazine helps manage ADHD symptoms [2].
What are the common side effects of viloxazine?
Common side effects reported in patients taking viloxazine include insomnia, decreased appetite, somnolence, nausea, vomiting, and fatigue [2].
Are there alternative ADHD treatments available?
Yes, several alternative medications and non-pharmacological approaches are used to manage ADHD. These include other stimulant and non-stimulant medications, as well as behavioral therapy and educational support [4].
Who manufactures the generic version of viloxazine?
Multiple pharmaceutical companies may produce generic versions of viloxazine. These manufacturers are approved by regulatory bodies to produce safe and effective generic drugs [1].
What is the typical cost of generic viloxazine?
The cost of generic medications generally varies depending on the pharmacy, insurance coverage, and dosage [5]. Generic drugs are typically less expensive than their brand-name counterparts [5].
What is the difference between viloxazine and other ADHD medications?
Viloxazine is a non-stimulant medication that selectively inhibits norepinephrine reuptake [2]. Other ADHD medications may include stimulants, which increase both dopamine and norepinephrine levels, or other non-stimulants with different mechanisms of action [4].
Sources:
1. https://www.drugpatentwatch.com/
2. https://www.rxlist.com/script/main/mobilearticl.jsp?articlekey=245088&ref=mobile
3. https://www.supernus.com/
4. https://www.additudemag.com/adhd-medications-stimulant-vs-non-stimulant/
5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132200/